Abstract:What's New? Tumor cells enhance glycolysis via the Warburg effect, producing excess lactic acid in the tumor microenvironment and suppressing immune cell proliferation and activation. However, how lactic acid affects regulatory B cells largely remains unclear. This study shows that tumor‐secreted lactic acid promotes acetylation at lysine 27 on histone H3 in splenic B cells and induces differentiation into IL‐10‐producing regulatory B cells. Lactic acid directly acts on B cells, enhancing the activation of the CD40 ligand‐CD40 signaling pathway. Moreover, lactic acid can indirectly increase regulatory B cells by activating non‐B cells through the EPAC signaling pathway. Tumor cells are known to enhance glycolysis, even under normoxic conditions, via the Warburg effect, producing excess lactic acid in the tumor microenvironment. Lactic acid enhances the IL‐23/IL‐17 pathway and induces chronic inflammation. The acidic microenvironment formed by lactic acid suppresses immune cell proliferation and activation. In the present study, we clarified that lactic acid had two novel activities for immune cells. First, lactic acid specifically enhanced acetylation at lysine 27 of histone H3 (H3K27ac) in splenic B cells and monocytes/macrophages, and this epigenetically up‐regulates the expression of genes. Acetylation and methylation of other residues of histone H3 were rarely induced. Second, lactic acid induced a particularly‐marked enhancement of Il10 gene expression in B cells, leading to an increase in IL‐10‐producing regulatory B (Breg) cells. Furthermore, two pathways should be involved in both the enhancement of H3K27ac and the induction of Breg cells by lactic acid: a direct pathway that enhances the CD40 signal in B cells, and an indirect pathway that affects B cells by activating the exchange protein directly activated by cAMP (EPAC) 1/2 in non‐B cells. In tumor‐bearing mice, the levels of H3K27ac of tumor‐infiltrating B cells were significantly higher than splenic B cells and were suppressed by intraperitoneal injection of the EPAC1/2 inhibitor. In conclusion, tumor‐derived lactic acid increases H3K27ac and IL‐10‐producing Breg cells, causing the suppression of anti‐tumor immunity.

Lactic acid inhibits iNKT cell functions via a phosphodiesterase-5 dependent pathway

Lactic Acid Inhibits the Cytotoxicity of NK-92 Cells via Activating the Lactate Receptor GPR81

Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling

Impaired Lipid Biosynthesis Hinders Anti-Tumor Efficacy Of Intratumoral Inkt Cells

The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function

Phosphodiesterase 4A Confers Resistance to PGE2-mediated Suppression in CD25+ /CD54+ NK Cells.

Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis.

Vam6 upregulated by lactic acid inhibits anti-tumor effects of intratumoral iNKT cells via modulating AMPK/mTOR pathways

Proliferation capability of natural killer cells upon cytokines stimulation correlated negatively with serum lactate dehydrogenase level in coronary artery disease patients

Tumor‐derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL‐10‐producing regulatory B cells through direct and indirect signaling pathways

The Inhibitory Role of Lactacystin and Beta-Lactacystin on T-Cell Activation and Proliferation

Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells

Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions

Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

Α-Lipoic Acid Inhibits the Effects of Iκβ Kinase Β on Islet

P015 iNKT cells immunomodulation and mucosal healing by microbiota-derived lactate

pH Low Insertion Peptide-Modified Programmed Cell Death-Ligand 1 Potently Suppresses T-Cell Activation Under Acidic Condition

Lactic acid promotes nucleus pulposus cell senescence and corresponding intervertebral disc degeneration via interacting with Akt

Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity

Activation of Invariant Natural Killer T Cells Impedes Liver Regeneration by Way of Both IFN-γ- and IL-4-dependent Mechanisms

Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression